Alan Bao focuses his practice on mergers and acquisitions, capital markets, and other general corporate matters. He represents clients in their going private, Hong Kong initial public offerings (IPOs), as well as in FIE, employment, and IP enforcement matters.
Alan understands that legal challenges can interrupt companies’ foci from their core business activities. He skillfully crafts solutions that enable his clients to retain energy for business management and development. Alan’s clients range from start-ups to Fortune 500 corporations and operate in a wide variety of industries such as financial services (including investment banks and private equity), consumer electronics and technology, health care, biotechnology, pharmaceuticals, gaming, entertainment, and aviation.
Prior to relocating to Beijing, Alan worked in the firm’s Los Angeles office.
- Currently representing a buyer consortium in the going private transaction of 111, Inc. (NASDAQ:YI)
- Advised Acotec Scientific on its approximately US$520 million voluntary partial offer by Boston Scientific
- Represented a buyer consortium led by Fang Holdings (OTC: SFUNY) in a going private transaction involving China Index Holdings (NASDAQ: CIH) valued at approximately US$92 million
- Represented a buyer consortium led by Yunfeng Capital, TF Capital, GIC and management in connection with the acquisition of Cellular Biomedicine Group (NASDAQ: CBMG), a biopharmaceutical company developing proprietary cell therapies for the treatment of cancer and degenerative diseases, in a "going private" transaction valued at approximately US$410 million
- Represented SEEK Limited in the sale of a controlling interests in a leading Chinese recruitment website at a US$1.7 billion valuation to Primavera-led consortium
- Represented TTM Technologies, Inc. (NASDAQ: TTMI) in the sale of substantially all of its China-based mobility business to Chinese consortium AKM Meadville Electronics (Xiamen) Co., Ltd. for a combination of $550 million in cash and an estimated $110 million in retained accounts receivable
- Represented the buyer group in going private transaction of China XD Plastics (NASDAQ: CXDC)
- Represented a buyer consortium led by the management in a “going private” transaction of SORL Auto Parts, Inc. (NASDAQ: SORL) valued at approximately US$96 million
- Represented TTM Technologies, Inc. (NASDAQ: TTMI) in its $775 million acquisition of Anaren, Inc. from Veritas Capital
- Represented the PKU-VMing (SZSE:002581) buyer consortium in a competing going private bid against management for a Chinese biopharmaceutical and vaccine company Sinovac Biotech Ltd. (NASDAQ: SVA)
- Represented an A-share listed preclinical research company in its acquisition of a US-based CRO company
- Represented Goldstone Investment as a member of buyer consortium in the going private transaction of Bona Film (NASDAQ: BONA)
- Represented the Meinian buyer consortium (SZSE:002044) in a competing going private bid against management for Chinese healthcare Company iKang Healthcare Group (NASDAQ: KANG)
- Represented Orient Ruide, a member of the buyer group and also a wholly owned subsidiary of Orient Securities (SSE: 600958) in connection with the merger closing of Taomee (NYSE: TAOM)'s going private transaction
- Represented iMeigu in its competing going private bid against the founders and management for Dangdang (NYSE: DANG)
- Represented Chinese hotel chain Homeinns (NASDAQ: HMIN) in US$1.75 billion going private transaction
- Represented a Chinese PE fund on its acquisition of a U.S. based film, television and music production and distribution company
- Represented an A share listed company in its outbound acquisition of a U.S. film studio
- Represented an A share listed company in its outbound acquisition of a Finnish entertainment company
- Represented Lions Gate Entertainment Corp. on co-financing arrangement with Hunan TV & Broadcast Intermediary Co., for distribution and co-development
- Advised Lions Gate Entertainment Corp. on various co-production opportunities in China
- Advised a U.S. film and TV production studio on its China development strategies
- Advised a U.S. film and entertainment company on its potential theme park development project in China
- Represented a US pre-clinical and clinical laboratory services company in its acquisition of a leading Chinese laboratory animal supplier
- Represented a Singapore-based private equity fund in its acquisition of a stake in one of the "Big 4" state-owned asset management companies
- Advised a global investment management company that acted as a senior lender of certain US real estate investments on its negotiation strategy with mezzanine lenders
- Advised a US private equity bondholder of a Chinese real estate developer group in its negotiation strategy with other lenders and with the real estate group as part of the group's onshore and offshore restructuring
- Advised a multinational group on Chinese bankruptcy/restructuring issues related to their onshore subsidiaries
- Advised a European company on the distressed sale of its China assets
Languages
- Mandarin
- Taiwanese
Admissions
Bar Admissions
- California
Court Admissions
- US Court of Appeals, District of Central California
- US District Court, District of Central California
- Superior Court, District of Central California
Education
- University of Southern California, J.D.; LL.M.
- China University of Political Science and Law, LL.B., third-class honors
Professional Activities
Clerkships
- The People's Supreme Court of People's Republic of China
Externships
- Honorable Samuel Bufford, US Bankruptcy Court, California (Central)
Member
- Student Bar Association (President), International Economic Law School, China University of Political Science and Law
- Los Angeles County Bar Association
Author
- “Comparative Studies of China's Enterprise Bankruptcy Law and the U.S. Bankruptcy Law,” Norton Journal of Bankruptcy Law and Practice (2010)
- “On the Validity of Parallel Import,” People's Judicature, China (2003)
- “The Legal Infrastructure, Judicial Independence and Economic Development,” The Forum for Civil and Commercial Justice, China (2006) (served as article editor and translator)